Search

everythinglearnresearchcommunity

for

Search:↓

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Higher CRBP1 levels are linked to more severe alopecia areata.

HAPLN1 can promote hair growth and may help treat hair loss.

Combining fractional CO2 laser with halometasone cream is more effective for chronic eczema than the cream alone.

Glycyrrhizinic acid spray showed limited effectiveness in treating anogenital warts in HIV patients with low CD4 levels.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

The treatment led to denser, thicker hair growth and less hair loss.

Suaeda glauca and its compounds could be new treatments for hair loss.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Understanding wound healing and signaling pathways could lead to new alopecia treatments.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

PCOS is linked to inflammation, and certain markers could help in its treatment.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

The document concludes that Hidradenitis suppurativa is often underdiagnosed, lacks definitive treatment, and requires better awareness and management strategies.

COVID-19 infection may trigger alopecia areata in some patients.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Dupilumab for skin problems might reactivate hair loss in some patients.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.